Chesson Labs | About Us

Chesson Labs is a healthcare products company founded in 2006. The company has sole licensing rights to all medical applications of a unique, patented polymer. Chesson Labs' technology is proprietary in nature and is based on patented and patent pending polymer formulations, which it intends to market once all necessary regulatory protocols have been satisfied.

Chesson Labs has its corporate headquarters in Durham, North Carolina, and has a separate Laboratory and Research and Development facility a few miles away. The company is in various developmental stages with many exciting products. Chesson Labs looks to introduce and bring many of the products to market as they are refined. Chesson Labs has made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its Liquid Bandage product. The Company anticipates market clearance for this product in the first half of 2009. The next product that Chesson Labs expects to bring to market is a nail fungus application which in preliminary research has shown overwhelming potential. Upon anticipated completion of clinical trials, Chesson Labs plans a submission to the FDA.

MISSION STATEMENT

To improve global healthcare by becoming a market leader in the development and delivery of innovative polymer-based medical products.


	About Us About Us \| Management \| Products \| Partnerships \| News \| Investors Home \| Contact \| Legal
	Chesson Labs is a healthcare products company founded in 2006. The company has sole licensing rights to all medical applications of a unique, patented polymer. Chesson Labs' technology is proprietary in nature and is based on patented and patent pending polymer formulations, which it intends to market once all necessary regulatory protocols have been satisfied. Chesson Labs has its corporate headquarters in Durham, North Carolina, and has a separate Laboratory and Research and Development facility a few miles away. The company is in various developmental stages with many exciting products. Chesson Labs looks to introduce and bring many of the products to market as they are refined. Chesson Labs has made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its Liquid Bandage product. The Company anticipates market clearance for this product in the first half of 2009. The next product that Chesson Labs expects to bring to market is a nail fungus application which in preliminary research has shown overwhelming potential. Upon anticipated completion of clinical trials, Chesson Labs plans a submission to the FDA. MISSION STATEMENT To improve global healthcare by becoming a market leader in the development and delivery of innovative polymer-based medical products.